Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether zoledronic acid given once yearly for two years to men and women after surgical repair of a recent hip fracture will significantly reduce the rate of a...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis
NCT06449742 · Vertebral Fracture, Osteoporosis
NCT07350044 · PENG Block, Hip Fracture Surgeries
NCT07474571 · Osteoarthitis, Osteoporosis
NCT06565910 · Femoral Neck Fractures, Femur Head Necrosis, and more
University of Alabama Hospital
Birmingham, Alabama
Osteoporosis Diagnostic Center
Eureka, California
Sharp Grossmont Hosptial
La Mesa, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions